Pfizer's Stock Sees Slight Decline, But Maintains Positive Trend Over Past Month

Pfizer ., a leading pharmaceutical company in the largecap industry, saw a decline of -3.37% in its stock on September 3rd, 2024. This drop in stock price was reflected in the stock call given by MarketsMOJO, which rated Pfizer's stock as 'Hold'.

The stock's performance today was lower than the sector average by -3.47%, indicating a slight underperformance. This also marks a trend reversal for Pfizer, as the stock had been on a five-day consecutive gain streak before this decline.

On the day of the decline, Pfizer's stock touched an intraday low of Rs 6097.15, which was a decrease of -3.54% from the previous day's closing price. However, despite this drop, Pfizer's stock is still trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages.

In comparison to the overall market performance, Pfizer's stock saw a -3.01% decline, while the Sensex only saw a -0.05% decline on the same day. However, over the past month, Pfizer's stock has outperformed the Sensex with a 8.26% increase, compared to the Sensex's 1.90% increase.

Overall, Pfizer's stock has shown a mixed performance in the recent days, with a slight decline on September 3rd, but still maintaining a positive trend over the past month. Investors may want to keep an eye on Pfizer's stock and monitor its performance in the coming days.